Heron Neutron Medical Corp. (TPE:7799)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
357.00
-4.50 (-1.24%)
At close: Aug 6, 2026

Heron Neutron Medical Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
11.6910.31-0.24-
Revenue Growth
482.12%----
Gross Profit
-18-25.78-3.590.13-
Operating Income
-592.71-534.32-259-129.51-87.8
Net Income
-479.38-481.67-260.08-126.39-86.18
Earnings Per Share
-3.11-3.31-2.04-1.18-1.13
EPS Growth
-----

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
9,41610,229823.97233.27156.12
Total Debt
235.867.239.5113.4217.26
Net Cash (Debt)
9,18010,221814.45219.85138.86
Net Cash Growth
1501.54%1155.00%270.46%58.33%-
Net Cash Per Share
59.3870.176.382.051.82

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-677.6-484.4-259.97-54.57-62.05
Capital Expenditures
-40.56-27.81-42.22-56.19-111.1
Free Cash Flow
-718.16-512.21-302.19-110.76-173.14
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
-153.96%-250.12%-54.20%-
Operating Margin
-5070.66%-5183.58%--54415.97%-
Pretax Margin
-4101.11%-4672.74%--53105.04%-
Profit Margin
-4101.11%-4672.74%--53105.04%-
FCF Margin
-6143.87%-4969.02%--46536.13%-

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
4825.446854.32---